Has Neil Sadick received payments from drug or device companies?

Yes. Drug and device makers reported $4,222,006 in general payments to Neil Sadick across 795 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Neil Sadick did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Neil Sadick come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Neil Sadick

Dermatology · New York, NYNPI 1841211422

Payments from drug & device makers

$4,222,006in general payments, 2019–2025

Across 795 payments — averaging $5310.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

E.r. Squibb & Sons, L.L.C.$758K
Bausch Health US, LLC$435K
Eli Lilly$383K
Takeda Pharmaceuticals U.S.A., Inc.$367K
Galderma Laboratories, L.p.$345K
Merz North America, Inc.$330K
plus $1.6M from 35 others

$46,558in research payments, 2019–2025

Across 18 payments — averaging $2586.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bausch Health US, LLC$39K
AbbVie$3K
Sanofi US Services Inc.$2K
Dr.reddy's Laboratories,inc.$2K
Eli Lilly$43

What the payments were for

Consulting fees$165,75830%
Grants$340,16762%
Travel & lodging$13,3942%
Food & beverage$24,9195%
Education$5180%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
E.r. Squibb & Sons, L.L.C.	39	$757,993
Bausch Health US, LLC	53	$435,375
Eli Lilly	26	$382,689
Takeda Pharmaceuticals U.S.A., Inc.	30	$366,520
Galderma Laboratories, L.p.	29	$344,977
Merz North America, Inc.	40	$330,028
Incyte Corporation	116	$300,690
Sanofi US Services Inc.	19	$217,815
Pfizer	43	$201,176
AbbVie(2 entities)	132	$188,104
Janssen Research & Development, LLC	51	$153,351
LEO Pharma AS	33	$113,398
GSK	21	$108,022
Aclaris Therapeutics, Inc.	16	$73,627
Amgen	15	$70,507
Sun Pharmaceutical Industries Inc.	9	$38,771
Bristol Myers Squibb	5	$33,395
Dermira, Inc.	9	$30,518
Vanda Pharmaceuticals Inc.	7	$17,453
Lumenis BE Inc	2	$13,902
Dr.reddy's Laboratories,inc.	3	$9,728
LEO Pharma Inc.	13	$6,735
Endo Pharmaceuticals Inc.	10	$6,379
UCB SA	2	$6,314
Ortho Dermatologics, A Division Of Bausch Health US, LLC	15	$6,057
VYNE Pharmaceuticals Inc.	3	$4,302
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$1,400
Johnson & Johnson	10	$428
Avita Medical Americas, LLC	2	$428
Novartis	9	$405
Almirall LLC	6	$339
UCB, Inc.	4	$245
Lilly USA, LLC	8	$219
Biofrontera Inc.	4	$212
Solta Medical, A Division Of Bausch Health US, LLC	2	$199
Acelrx Pharmaceuticals, Inc.	1	$110
Regeneron Healthcare Solutions, Inc.	2	$61
Stemline Therapeutics Inc.	1	$57
Sanofi	1	$37
Journey Medical Corporation	1	$24
Sandoz	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BOTOX$25,177
BOTOX COSMETIC$15,493
M22$13,902
XEOMIN$779
ARAZLO$700
RECELL$428
Rinvoq$271
ADBRY$243
COSENTYX$229
ASCLERA$220
Tremfya$150
AMELUZ$131
BF-RhodoLED$131
XEPI$131
Cimzia$115
SILIQ$115
DSUVIA$110

How this compares

$4,222,006 in reported general payments places this provider in the 95th percentile of 1,151 dermatology providers in New York.

See all dermatology providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Minoxidil	39	$528
Dutasteride	15	$413

Paid to pharmacies, not to this prescriber.

Other dermatology in New York

Emma GuttmanNew York$35.3M
Saakshi KhattriNew York$15.4M
James KruegerNew York$6.3M
Michael CameronNew York$5.8M
Mark LebwohlNew York$5.8M
Andrew AlexisNew York$5.7M
Orit MarkowitzNew York$3.7M
Alexandra GolantNew York$3.6M
George HanNew York$3.4M
David CohenNew York$3M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →